Skip to main content
C

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 TW Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
代子公司「中國化學製藥股份有限公司」董事會通過對 「社團法人中華民國學名藥協會」捐贈案
Regulatory Filings
2026-04-30 Chinese
公告本公司115年第1季合併財務報告董事會預計召開日期為 115年5月5日
Report Publication Announcement Classification · 1% confidence The document is a brief announcement by the listed company (3716 中化控股) notifying the market of the scheduled board meeting date (May 5) to review and release the Q1 consolidated financial report for the 115th year. It does not contain the actual financial report, but only the timing of its board approval. This fits the definition of a Report Publication Announcement (RPA).
2026-04-27 Chinese
115年年報及股東會資料 — 2026_3716_20260526F17.pdf
Major Shareholding Notification Classification · 1% confidence The document is a shareholder disclosure listing the top ten shareholders by holding percentage and detailing their interrelationships (related persons/spouses/second‐degree relatives). This falls under a major shareholding notification rather than a full report, earnings release, or board change. Therefore it matches the “Major Shareholding Notification” category (MRQ).
2026-04-24 Chinese
115年年報及股東會資料 — 2026_3716_20260526FE2.pdf
Regulatory Filings
2026-04-24 Chinese
115年年報及股東會資料 — 2026_3716_20260526FE1.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of the 2026 Regular Shareholders’ Meeting, including the meeting agenda, proposals, reports, proxy instructions, and attachments for voting. It is sent to shareholders to provide information and solicit their votes for the upcoming general meeting. This aligns precisely with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
115年年報及股東會資料 — 2026_3716_20260526F02.pdf
AGM Information Classification · 1% confidence The document is the comprehensive meeting handbook for the company’s 2026 Annual General Shareholders’ Meeting (“股東常會議事手冊”), including agenda items, reports (business report, financial statements, audit committee report), proposals for approval, discussion items, appendices with the annual business report, audited financial statements, auditor’s report, and other meeting materials. This matches the definition of AGM Information (materials shared during the Annual General Meeting).
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.